-
Dr. Huilai Zhang’s Team: Key Research in the Field of Hodgkin Lymphoma
The 28th European Hematology Conference/Annual Meeting (28th EHA Congress) was successfully held in Frankfurt, Germany from June 8-11, 2023. The conference was organized by the European Hematology Association (EHA). As one of the largest international conferences in the field of hematology worldwide, the EHA annual meeting gathered top hematology experts from around the globe, covering…
-
Dr. Liu Hongxing and Wang Tong: Decoding Structural Aberrations of the PAX5 Gene in B-ALL and its Correlation with Diagnostic Classification and Treat
Researcher in Clinical Medicine Director of the Cellular and Molecular Cytogenetics Laboratory at Ludaopei Medical Group Corresponding Author Executive Dean of Beijing Ludaopei Hematology Research Institute, Chief of the Department…
-
Dr. Niels Van de Donk Interprets the Latest Research Progress on CAR-T Treatment for RRMM
From June 8th to 11th, 2023, the 28th European Hematology Association (EHA) was held in Frankfurt, Germany, both online and offline. The conference was hosted by the European Hematology Association. As the largest international conference in the European hematology field, it attracts over 10,000 professionals from more than 100 countries each year to share and…
-
Dr. Qian Jiang: Reduced Dosage without Reducing Efficacy, Better Quality of Life for Patients
From June 8th-11th, 2023, the 28th European Hematology Association (EHA) conference was held in Frankfurt, Germany. At the EHA meeting, Professor Jiang Qian’s team from Peking University People’s Hospital reported on the results of a study on reducing treatment doses for Chronic Myeloid Leukemia (CML) patients after achieving major molecular remission (abstract S158). During the…
-
Dr. Nyaradzo Mgodi’s Insights on Long-Acting PrEP and Cabotegravir Roll-Out for HIV Prevention
In the realm of HIV prevention, the emergence of long-acting injectable PrEP (pre[1]exposure prophylaxis) has marked a significant advancement. Dr. Nyaradzo Mavis Mgodi, a seasoned clinical pathologist with extensive experience…
-
Challenges of Clostridioides difficile Infection in Children: Insights from Anne J. Gonzales-Luna at ECCMID 2023
The 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), held in Copenhagen, Denmark from April 15th to 18th, 2023, provided a valuable platform for healthcare professionals to delve…
-
Antimicrobial Susceptibility Testing: The Joint Efforts of CLSI and EUCAST丨ECCMID 2023
Antimicrobial susceptibility testing (AST) is pivotal in both individualized and empirical treatments. Notably, standards set for interpreting AST results enable clinicians to choose suitable medications and optimal treatment plans, acting as a significant tool in controlling antimicrobial resistance. The most influential bodies in this space are the Clinical and Laboratory Standards Institute (CLSI) of the…
-
Exploring the Path to HTLV-1 Elimination: Insights from ECCMID 2023 Interview with Dr. Graham Taylor
The 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), held in Copenhagen, Denmark from April 15th to 18th, 2023, provided a platform for significant discussions in the field…
Connecting Medical Expertise through Media